CompletedPhase 2

Triamcinolone Assisted Anterior Vitrectomy

Egypt10 participantsStarted 2007-12

Plain-language summary

Injecting Triamcinolone acetenoide for visualizing and removing vitreous from the anterior chamber.

Who can participate

Age range47 Years – 79 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with vitreous in the anterior chamber whether in * complicated cataract surgery * disorganized anterior segment structures Exclusion Criteria: * Glaucoma patients * Intra ocular infections * Bacterial or fungal

What they're measuring

Proper visualization of vitreous strands in the anterior chamber of the eye

Timeframe: immediately

Trial details

NCT IDNCT01051648

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-02

View on ClinicalTrials.gov More Vitrectomy trials